Auris Health announces $220 M growth financing

Auris Health, Inc. has announced the close of a $220 million equity financing led by Partner Fund Management. New invest...

December 3, 2018 | Monday | News
Biocartis, AstraZeneca aim faster lung cancer biomarker results

Biocartis Group NV, an innovative molecular diagnostics company, has entered into an agreement with AstraZeneca, a globa...

December 3, 2018 | Monday | News
FDA approves first treatment developed by Catalyst Pharma for LEMS

The U.S. Food and Drug Administration has approved Firdapse (amifampridine) tablets for the treatment of Lambert-Eaton m...

December 1, 2018 | Saturday | News
Roche buys Jecure Therapeutics

Jecure Therapeutics Inc., a biotechnology company with novel drug discovery programs targeting serious inflammatory dise...

November 29, 2018 | Thursday | News
GE Healthcare to open biotech manufacturing centre in UK

GE Healthcare has announced the opening of a biotechnology manufacturing centre at the Stevenage Bioscience Catalyst (SB...

November 28, 2018 | Wednesday | News
Incyte appoints new CSO

Pharma company, Incyte has announced the appointment of Dashyant Dhanak as Executive Vice President and Chief Scientific...

November 28, 2018 | Wednesday | News
Roivant launches Aruvant Sciences

US based pharma company Roivant Sciences and Cincinnati Children’s Hospital Medical centre has announced...

November 28, 2018 | Wednesday | News
Frazier Healthcare Partners adds experienced executive search professional to Life Sciences team

Frazier Healthcare Partners has announced Mimi Hancock, Ph.D. has joined its Life Sciences team as a Senior Advisor to a...

November 28, 2018 | Wednesday | News
Receptor Life Sciences announces senior leadership

Receptor Life Sciences has announced the appointment of Orrin Devinsky, M.D., as the company’s Chief Medical Offic...

November 28, 2018 | Wednesday | News
WHO introduces new digital platform addressing NCDs

The World Health Organization (WHO) has launched a new community-driven platform - the Knowledge Action Portal (KAP) - f...

November 28, 2018 | Wednesday | News
CURE Pharma gets USDEA nod to develop cannabinoid-based products

CURE Pharmaceutical, an innovative drug delivery and development company, has secured a new registration with the Drug E...

November 28, 2018 | Wednesday | News
Philip Gutry appointed as Chief Business Officer by Kronos Bio

U.S. based Kronos Bio has announced that it has appointed Philip Gutry as its Chief Business Officer. In this newly cre...

November 28, 2018 | Wednesday | News
Merck Foundation underscores partnership with Health ministry of C.A.R.

Merck Foundation, the philanthropic arm of Merck Germany underscored their commitment to build healthcare capacity in th...

November 28, 2018 | Wednesday | News
Aspen launches novel HIV drug combination

Aspen Pharmacare, South Africa’s leading JSE-listed pharmaceutical company, is pleased to announce the launch of E...

November 28, 2018 | Wednesday | News
Axovant strengthens team to support gene therapy pipeline

Clinical-stage gene therapy company Axovant has announced the addition of five senior team members to strengthen its exp...

November 27, 2018 | Tuesday | News
DRC initiates first-ever multi-drug Ebola trial

First-ever multi drug trial for an Ebola treatment has been announced by The Ministry of Health of the Democratic Republ...

November 27, 2018 | Tuesday | News
REGENXBIO, Rocket Pharma partner for Danon disease

REGENXBIO Inc, a leading clinical-stage biotechnology company seeking to improve lives through the curative potential of...

November 26, 2018 | Monday | News
Cobra, Pall, Cell and Gene Therapy Catapult win £1.5M Innovate UK grant

Singapore –Cobra Biologics, an international contract development and manufacturing organization (CDMO) ...

November 26, 2018 | Monday | News